Search

Your search keyword '"SPADARO, Giuseppe"' showing total 242 results

Search Constraints

Start Over You searched for: Author "SPADARO, Giuseppe" Remove constraint Author: "SPADARO, Giuseppe" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
242 results on '"SPADARO, Giuseppe"'

Search Results

2. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study

3. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

8. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

9. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)

12. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

13. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

14. Severe asthma: One disease and multiple definitions

15. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best

17. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

18. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

19. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

20. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.

22. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

23. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality

24. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

27. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies

28. The Severe Asthma Network in Italy: Findings and Perspectives

29. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

30. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.

32. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

36. Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia

39. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

41. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review.

42. Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.

43. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.

44. Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).

45. Is there a role for microbiome-based approach in common variable immunodeficiency?

Catalog

Books, media, physical & digital resources